R&D focus is increasing in India
Shalini Gupta finds out more in an interview with Adefemi Adenuga, GlobalDatas Healthcare Analyst covering industry dynamics
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
SC asks centre to discuss clinical trial regulation with state/ UT health authorities
PIL petitioners to submit suggestions in two weeks; ISCR expresses concerns on slowdown of trial approvals
State/ UTs drug regulators await order to monitor drug price revision process
Karnataka state regulators write to state govt; Maharashtra and Gujarat gears up for action
Claris Lifesciences completes transfer of infusion biz in India and emerging markets to Otsuka JV
Receives a total cash consideration of Rs 1050 crores as a part of the transaction from Claris-Otsuka
Intas finalises corporate plans post IPO
Focuses on European market and setting up of a new R&D centre in Ahmedabad
IMA opposes proposed one year pharmacology course for non MBBS doctors
Alleges that the real problem is infrastructure not availability of doctors
Zydus and IDRI sign agreement
Zydus & IDRI will collaborate to conduct clinical development activities in India for visceral leishmaniasis (Kala-Azar)
Piramal Enterprises receives IND approval from US FDA
P7435 is a novel DGAT1 inhibitor for treatment of lipid disorders and diabetes
Increasing product pipelines in acute care environment drive M&A activity
Witnesses no deals during July 2013
BIORx launches BIO-Accelerator Programme
Programme is devised for working executives, Ph.d scholars and post-doctoral scientists aspiring to accelerate the path of their…